세부
Molnucen (Molnupiravir 200 mg) is an oral antiviral medication indicated for the treatment of mild to moderate COVID-19 in adults at high risk for severe illness. It works by causing lethal mutations in the viral RNA of SARS-CoV-2, effectively preventing replication and reducing viral load in the body.
Key Benefits:
Helps reduce risk of hospitalization and severe COVID-19 outcomes
Ideal for early-stage COVID-19 treatment (within 5 days of symptom onset)
Oral capsule form – no injections or hospital visits required
FDA Emergency Use Authorized in several regions (check local approvals)
Can be used in home isolation under medical guidance
Quantity- 40 Capsules
Shop now- https://mediwindow.com/product..../molnucen-molnupirav
관련 상품
